東瀛遊(06882.HK):下午將免費派發千八個口罩 港人優先
東瀛遊(06882.HK)在官方Facebook公布,眼見疫情蔓延,香港口罩嚴重缺貨,會率先係今日(31日)下午4時30分為香港市民免費派發共1,800個合規格口罩,地點為尖沙咀漆咸道南45-51號 其士大廈5樓(尖沙咀地鐵站B2出口)。
派發細則:每位可獲5個口罩,合共360個名額,並會以派籌形式進行,額滿即止,以免人流聚集。今次派發以香港人優先。
東瀛遊指,公司管理層啟動危急應變小組,近日馬不停蹄地聯絡日韓合作夥伴,至今成功找到2萬個口罩,並想盡辦法用最迅速方式運抵香港,解決市民燃眉之急。衷心感謝日本茨城縣、德島縣及鹿兒島縣政府,以及前線同事全力幫忙搜羅到第一批口罩。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.